Want to join the conversation?
Biopharmaceutical company $HALO posted a net loss for 3Q15 of $24.5MM or $0.19 per share compared to a net loss in 3Q14 of $20.3MM or $0.16 per share. The company's revenue for the quarter increased 42% YoverY to $20.8MM, driven primarily by an increase in royalties from partner sales of Herceptin SC, MabThera SC and HyQvia.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?